Authors
Chaganti, SIllidge, Timothy M
Barrington, S
Mckay, Pam
Linton, Kim M
Cwynarski, K
McMillan, A
Davies, A
Stern, S
Peggs, K
Affiliation
Department of Haematology, Queen Elizabeth Hospital, BirminghamIssue Date
2016-05-16
Metadata
Show full item recordCitation
Guidelines for the management of diffuse large B-cell lymphoma. 2016: Br J HaematolJournal
British Journal of HaematologyDOI
10.1111/bjh.14136PubMed ID
27196701Type
ArticleLanguage
enISSN
1365-2141ae974a485f413a2113503eed53cd6c53
10.1111/bjh.14136
Scopus Count
Collections
Related articles
- Long-term follow-up of patients with HIV-related diffuse large B-cell lymphomas treated in a phase II study with rituximab and CHOP.
- Authors: Ribera JM, Morgades M, González-Barca E, Miralles P, López-Guillermo A, Gardella S, López A, Abella E, García M, Navarro JT, Feliu E
- Issue date: 2012 Jun
- BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma.
- Authors: Palickova M, Mocikova H, Vernerova Z, Campr V, Kozak T
- Issue date: 2013 Sep
- High-risk diffuse large B-cell lymphoma: can we do better than rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone?
- Authors: George A, Tam CS, Seymour JF
- Issue date: 2013 Dec
- Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.
- Authors: Younes A, Thieblemont C, Morschhauser F, Flinn I, Friedberg JW, Amorim S, Hivert B, Westin J, Vermeulen J, Bandyopadhyay N, de Vries R, Balasubramanian S, Hellemans P, Smit JW, Fourneau N, Oki Y
- Issue date: 2014 Aug
- Long-term remission of paroxysmal nocturnal hemoglobinuria following chemoimmunotherapy for non-Hodgkin lymphoma.
- Authors: Lai S, Venugopal P, Leslie W
- Issue date: 2012 Feb